ATE102928T1 - Salpetersaeureester-derivate. - Google Patents
Salpetersaeureester-derivate.Info
- Publication number
- ATE102928T1 ATE102928T1 AT88111490T AT88111490T ATE102928T1 AT E102928 T1 ATE102928 T1 AT E102928T1 AT 88111490 T AT88111490 T AT 88111490T AT 88111490 T AT88111490 T AT 88111490T AT E102928 T1 ATE102928 T1 AT E102928T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- alkylene
- suitable substituent
- substituted
- hydrogen
- Prior art date
Links
- 150000002823 nitrates Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000002947 alkylene group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000005529 alkyleneoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000001893 nitrooxy group Chemical group [O-][N+](=O)O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878717068A GB8717068D0 (en) | 1987-07-20 | 1987-07-20 | Nitric ester derivative |
| EP88111490A EP0300400B1 (en) | 1987-07-20 | 1988-07-16 | Nitric acid ester derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE102928T1 true ATE102928T1 (de) | 1994-04-15 |
Family
ID=10620954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88111490T ATE102928T1 (de) | 1987-07-20 | 1988-07-16 | Salpetersaeureester-derivate. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US4923886A (enExample) |
| EP (1) | EP0300400B1 (enExample) |
| JP (1) | JPH0228167A (enExample) |
| KR (1) | KR890002067A (enExample) |
| CN (1) | CN1021046C (enExample) |
| AT (1) | ATE102928T1 (enExample) |
| AU (1) | AU623858B2 (enExample) |
| DE (1) | DE3888415T2 (enExample) |
| DK (1) | DK375988A (enExample) |
| FI (1) | FI883402L (enExample) |
| GB (1) | GB8717068D0 (enExample) |
| HU (1) | HU203227B (enExample) |
| IL (1) | IL86959A (enExample) |
| MX (1) | MX12317A (enExample) |
| NO (1) | NO172049C (enExample) |
| PH (1) | PH24481A (enExample) |
| PT (1) | PT88019B (enExample) |
| SU (2) | SU1706388A3 (enExample) |
| ZA (1) | ZA884987B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3941438A1 (de) * | 1989-12-15 | 1991-06-20 | Hoechst Ag | Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
| IT1243367B (it) * | 1990-07-26 | 1994-06-10 | Italfarmaco Spa | Derivati acidi benzoici sostituiti ad attivita' cardiovascolare |
| US5298516A (en) * | 1991-03-27 | 1994-03-29 | Sankyo Company, Limited | Thiazolidone compounds and method of using the same as a vasodilator |
| JP3454531B2 (ja) * | 1991-11-07 | 2003-10-06 | 三共株式会社 | ニトロキシアルキルアミド誘導体 |
| IT1256450B (it) * | 1992-11-26 | 1995-12-05 | Soldato Piero Del | Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione |
| ES2161916T3 (es) * | 1994-12-15 | 2001-12-16 | Sankyo Co | Derivados de la tiazolidinona o de la oxazolidinona para el tratamiento de la angina de pecho y composiciones que las contienen como ingrediente activo. |
| US5925658A (en) * | 1995-03-02 | 1999-07-20 | Sankyo Company, Limited | Optically active thiazolidinone derivative |
| WO1996026931A1 (en) * | 1995-03-02 | 1996-09-06 | Sankyo Company, Limited | Optically active thiazolidinone derivatives |
| IL120531A (en) | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
| EP2308833A3 (en) | 1999-04-15 | 2011-09-28 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| JP4216193B2 (ja) * | 2001-11-27 | 2009-01-28 | エフ．ホフマン−ラ ロシュ アーゲー | ベンゾチアゾール誘導体 |
| US6624163B2 (en) * | 2001-11-29 | 2003-09-23 | Hoffman-La Roche Inc. | Benzothiazole derivatives |
| US6933308B2 (en) * | 2002-12-20 | 2005-08-23 | Bristol-Myers Squibb Company | Aminoalkyl thiazole derivatives as KCNQ modulators |
| US7273866B2 (en) * | 2002-12-20 | 2007-09-25 | Bristol-Myers Squibb Company | 2-aryl thiazole derivatives as KCNQ modulators |
| US7968575B2 (en) * | 2004-05-05 | 2011-06-28 | Renopharm Ltd. | Nitric oxide donors and uses thereof |
| WO2005105765A1 (en) * | 2004-05-05 | 2005-11-10 | Renopharm Ltd. | Nitric oxide donors and uses thereof |
| US8134010B2 (en) * | 2004-05-05 | 2012-03-13 | Renopharm Ltd. | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof |
| DE102009037555A1 (de) * | 2009-08-13 | 2011-03-03 | Synovo Gmbh | Ein neuartiges, schonendes Verfahren zur direkten Nitrierung von Hydroxyl-, Thiol- und Aminogruppen in organischen Molekülen mittels in situ generiertem Kohlensäuredinitrat |
| KR101045041B1 (ko) * | 2009-10-27 | 2011-06-28 | (주)에스엠이엔지 | 봉합침 제조방법 |
| CA2839390C (en) * | 2011-10-24 | 2015-09-15 | Nicox S.A. | Quinone based nitric oxide donating compounds |
| AU2013304942A1 (en) * | 2012-08-23 | 2015-03-05 | Cardiolynx Ag | Extended release compositions of an aminoalkyl nitrate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
| DE3244178A1 (de) * | 1982-11-30 | 1984-05-30 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| DE3433383A1 (de) * | 1984-09-12 | 1986-03-20 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue phenyl-acetonitril-derivate |
-
1987
- 1987-07-20 GB GB878717068A patent/GB8717068D0/en active Pending
-
1988
- 1988-06-30 US US07/213,623 patent/US4923886A/en not_active Expired - Fee Related
- 1988-07-01 PH PH37159A patent/PH24481A/en unknown
- 1988-07-03 IL IL86959A patent/IL86959A/xx unknown
- 1988-07-06 DK DK375988A patent/DK375988A/da not_active Application Discontinuation
- 1988-07-11 ZA ZA884987A patent/ZA884987B/xx unknown
- 1988-07-15 JP JP63177362A patent/JPH0228167A/ja active Granted
- 1988-07-15 PT PT88019A patent/PT88019B/pt not_active IP Right Cessation
- 1988-07-16 EP EP88111490A patent/EP0300400B1/en not_active Expired - Lifetime
- 1988-07-16 DE DE3888415T patent/DE3888415T2/de not_active Expired - Fee Related
- 1988-07-16 AT AT88111490T patent/ATE102928T1/de not_active IP Right Cessation
- 1988-07-18 MX MX1231788A patent/MX12317A/es unknown
- 1988-07-18 FI FI883402A patent/FI883402L/fi not_active Application Discontinuation
- 1988-07-19 CN CN88104473A patent/CN1021046C/zh not_active Expired - Fee Related
- 1988-07-19 NO NO883208A patent/NO172049C/no unknown
- 1988-07-19 KR KR1019880008995A patent/KR890002067A/ko not_active Withdrawn
- 1988-07-19 SU SU884356158A patent/SU1706388A3/ru active
- 1988-07-19 HU HU883775A patent/HU203227B/hu not_active IP Right Cessation
- 1988-07-20 AU AU19199/88A patent/AU623858B2/en not_active Ceased
-
1989
- 1989-06-19 SU SU894614353A patent/SU1760984A3/ru active
-
1990
- 1990-03-16 US US07/494,545 patent/US5010093A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO883208D0 (no) | 1988-07-19 |
| DE3888415D1 (de) | 1994-04-21 |
| PT88019B (pt) | 1995-03-01 |
| US5010093A (en) | 1991-04-23 |
| PT88019A (pt) | 1989-06-30 |
| JPH0228167A (ja) | 1990-01-30 |
| EP0300400B1 (en) | 1994-03-16 |
| MX12317A (es) | 1993-09-01 |
| FI883402A0 (fi) | 1988-07-18 |
| NO172049B (no) | 1993-02-22 |
| KR890002067A (ko) | 1989-04-07 |
| NO883208L (no) | 1989-01-23 |
| IL86959A0 (en) | 1988-12-30 |
| HU203227B (en) | 1991-06-28 |
| NO172049C (no) | 1993-06-02 |
| ZA884987B (en) | 1989-05-30 |
| GB8717068D0 (en) | 1987-08-26 |
| AU623858B2 (en) | 1992-05-28 |
| AU1919988A (en) | 1989-01-27 |
| US4923886A (en) | 1990-05-08 |
| DK375988A (da) | 1989-01-21 |
| DK375988D0 (da) | 1988-07-06 |
| PH24481A (en) | 1990-07-18 |
| CN1031226A (zh) | 1989-02-22 |
| SU1760984A3 (ru) | 1992-09-07 |
| HUT47551A (en) | 1989-03-28 |
| IL86959A (en) | 1992-12-01 |
| JPH0331709B2 (enExample) | 1991-05-08 |
| SU1706388A3 (ru) | 1992-01-15 |
| FI883402A7 (fi) | 1989-01-21 |
| FI883402L (fi) | 1989-01-21 |
| CN1021046C (zh) | 1993-06-02 |
| DE3888415T2 (de) | 1994-07-14 |
| EP0300400A1 (en) | 1989-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE102928T1 (de) | Salpetersaeureester-derivate. | |
| NO903438L (no) | Fremgangsmaate for fremstilling av tiazolderivater. | |
| CA2126327A1 (en) | Amidino derivatives and their use as nitric oxide synthase inhibitors | |
| NO913750D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| HU900064D0 (en) | Process for preparation of new 2-amino pyrimidinone-derivatives | |
| AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| ATE84035T1 (de) | Antivirale tetrahydroimidazo(1,4)benzodiazepin-2- one. | |
| PT95854A (pt) | Processo para a preparacao de composicoes contendo derivados de pirimidona e analogos, uteis no tratamento da asma e de certas perturbacoes da pele | |
| DE3164314D1 (en) | Azolylalkyl derivatives, process for their preparation and their use as fungicides | |
| ES8701143A1 (es) | Un procedimiento para la preparacion de nuevos aminas terciarias. | |
| EP0263506A3 (en) | Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative | |
| ZA885358B (en) | Uricosuric composition | |
| ES2061579T3 (es) | Compuestos cefem y procedimientos para su preparacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |